Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III clinical trial JadiCell adult stem cells in treatment of acute respiratory distress syndrome (ARDS)

Next Previous
Trial Profile

Phase III clinical trial JadiCell adult stem cells in treatment of acute respiratory distress syndrome (ARDS)

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 24 Apr 2023 New trial record
  • 20 Apr 2023 According to a Therapeutic Solutions International media release, the company announced the filling of a III clinical trial application with the FDA based on the Company's existing data and experiences associated with its Phase III clinical trial in the area of COVID-19 associated ARDS.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top